Stock Market News2 days Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock Zacks
Valneva reports positive data from its Phase 3 – VLA1553-321 study of the IXCHIQ vaccine.
XValneva reports positive data from its Phase 3 – VLA1553-321 study of the IXCHIQ vaccine.
X